Sigma Investment Counselors Inc Vertex Pharmaceuticals Inc Transaction History

Sigma Investment Counselors Inc

  • $2.05 Billion
  • Q3 2024

A detailed history of Sigma Investment Counselors Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Sigma Investment Counselors Inc holds 8,937 shares of VRTX stock, worth $3.65 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
8,937
Previous 8,677 3.0%
Holding current value
$3.65 Million
Previous $4.07 Million 2.19%
% of portfolio
0.2%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024
BUY
$460.0 - $505.78 $119,600 - $131,502
260 Added 3.0%
8,937 $4.16 Million
Q2 2024

Jul 25, 2024
BUY
$392.81 - $485.53 $202,297 - $250,047
515 Added 6.31%
8,677 $4.07 Million
Q1 2024

Apr 25, 2024
BUY
$407.69 - $446.08 $370,997 - $405,932
910 Added 12.55%
8,162 $3.41 Million
Q4 2023

Jan 22, 2024
BUY
$343.0 - $410.68 $2.03 Million - $2.43 Million
5,909 Added 439.99%
7,252 $2.95 Million
Q3 2023

Oct 23, 2023
BUY
$338.18 - $362.46 $25,025 - $26,822
74 Added 5.83%
1,343 $467,000
Q4 2022

Jan 27, 2023
SELL
$285.76 - $321.48 $3,714 - $4,179
-13 Reduced 1.01%
1,269 $0
Q3 2022

Oct 24, 2022
SELL
$273.83 - $305.53 $2,464 - $2,749
-9 Reduced 0.7%
1,282 $371,000
Q1 2022

Apr 20, 2022
SELL
$221.42 - $260.97 $182,892 - $215,561
-826 Reduced 39.02%
1,291 $337,000
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $22,480 - $28,378
127 Added 6.38%
2,117 $465,000
Q3 2021

Nov 05, 2021
BUY
$181.39 - $202.99 $26,845 - $30,042
148 Added 8.03%
1,990 $361,000
Q2 2021

Aug 04, 2021
BUY
$187.49 - $221.1 $5,062 - $5,969
27 Added 1.49%
1,842 $371,000
Q1 2021

Apr 30, 2021
BUY
$207.02 - $241.31 $55,067 - $64,188
266 Added 17.17%
1,815 $390,000
Q4 2020

Feb 04, 2021
BUY
$207.01 - $276.09 $320,658 - $427,663
1,549 New
1,549 $366,000
Q3 2020

Oct 20, 2020
SELL
$255.65 - $303.1 $250,537 - $297,038
-980 Closed
0 $0
Q2 2020

Jul 31, 2020
BUY
$225.48 - $295.8 $220,970 - $289,884
980 New
980 $285,000
Q3 2019

Oct 18, 2019
SELL
$166.23 - $187.09 $195,652 - $220,204
-1,177 Closed
0 $0
Q2 2019

Jul 23, 2019
BUY
$164.61 - $190.37 $3,621 - $4,188
22 Added 1.9%
1,177 $216,000
Q1 2019

Apr 26, 2019
BUY
$163.73 - $194.7 $189,108 - $224,878
1,155 New
1,155 $212,000
Q4 2018

Feb 01, 2019
SELL
$151.91 - $192.21 $177,582 - $224,693
-1,169 Closed
0 $0
Q3 2018

Oct 23, 2018
BUY
$167.73 - $192.74 $196,076 - $225,313
1,169 New
1,169 $225,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Sigma Investment Counselors Inc Portfolio

Follow Sigma Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email